The fine art of prescribing obesity drugs off-label is about to become even more complicated.

Are you prepared for the conflict of interest this will create?

For years, medical practitioners have threaded the fine needle of prescribing medications off-label for the benefit of our patients.

Given the number of patients involved in this activity has been small and the associated costs minimal, the authorities have, by and large, ignored any potential breach of the regulations, and medical practitioners have glossed over the possible medicolegal consequences.